Director Melvin L. Flowers filed a Form 4 with the SEC on November 12, 2026, reporting the grant of 645 Deferred Stock Units and 2,659 stock options in Broadridge Financial Solutions, Inc. on November 10, 2026.

Key Highlights

  • DSU Grant: Melvin L. Flowers received 645 Deferred Stock Units on November 10, 2026, at a price of $0.0000, under Broadridge's 2018 Omnibus Award Plan.
  • Vesting Terms: According to the filing, the Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service.
  • Stock Options: Flowers also received 2,659 stock options (right to buy) on November 10, 2026, at an exercise price of $192.96, vesting immediately upon grant.
  • Option Expiration: The stock options are exercisable beginning November 10, 2026, and expire on November 10, 2036, per the filing.
  • Post-Transaction Holdings: Following these transactions, Flowers directly holds 3,357 shares of common stock and 2,659 derivative securities beneficially owned directly.
  • Issuer: The filing identifies the issuer as Broadridge Financial Solutions, Inc., listed under ticker NYSE:BR.

Broadridge Director Flowers Receives Annual Equity Grants in November 2026

According to the Form 4 filed on November 12, 2026, Melvin L. Flowers, a director of Broadridge Financial Solutions, Inc. (NYSE:BR), reported two equity grants dated November 10, 2026. The first was an acquisition of 645 Deferred Stock Units (DSUs) under Broadridge's 2018 Omnibus Award Plan, recorded at a price of $0.0000. The filing notes that these DSUs "vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge."

The second transaction was the grant of 2,659 stock options (right to buy common stock) at an exercise price of $192.96 per share. Per the filing, these options also vest immediately upon grant and carry an expiration date of November 10, 2036. Both transactions are classified with transaction code "A" (acquired) and are held directly by the reporting person.

Following these reported transactions, the filing states that Flowers beneficially owns 3,357 shares of Broadridge common stock directly, and holds 2,659 derivative securities (the stock options) directly. The form was signed by Maria Allen under power of attorney and filed on November 12, 2026.

What Was Disclosed

Director Melvin L. Flowers disclosed the receipt of 645 Deferred Stock Units and 2,659 immediately vesting stock options in Broadridge Financial Solutions on November 10, 2026, resulting in direct beneficial ownership of 3,357 common shares and 2,659 options.